Bone Marrow Stromal Cell Line Promotes the Proliferation of Mast Cell Progenitors Derived from Cord Blood CD34⁺ Cells under Serum-free Conditions with a Combination of Both Cell-cell Interaction and Soluble Factors

REFERENCES

• Ishizaka, T., Ishizaka, K. (1984). Activation of mast cells for mediator release though IgE receptors. Prog Allergy 34: 188–235.
   PubMedGoogle Scholar
• Galli, S.J., Wershil, B.K. (1996). The two faces of mast cells. Nature 381: 21–22.
   PubMed Web of Science ®Google Scholar
• Galli, S.J., Grimbaldeston, M., Tsai, M. (2008). Immunomodulatory mast cells: negative, as well as positive, regulators of innate and acquired immunity. Nat Rev Immunol 8: 478–486.
   PubMed Web of Science ®Google Scholar
• Kalesnikoff, J., Galli, S.J. (2008). New developments in mast cell biology. Nat Immunol 9: 1215–1223.
   PubMed Web of Science ®Google Scholar
• Yamaguchi, M., Azuma, H., Fujihara, M., Hamada, H., Ikeda, H. (2007). Generation of a considerable number of functional mast cells with a high basal level of FcεRI expression from cord blood CD34+ cells by co-culturing them with bone marrow stromal cell line under serum-free conditions. Scad J Immuno. 65: 581–588.
   PubMedGoogle Scholar
• Kawano, Y., Kobune, M., Yamaguchi, M., Nakamura, K., Ito, Y., Sasaki, K., Takahashi, S., Nakamura, T., Chiba, H., Sato, T., Matsunaga, T., Azuma, H., Ikebuchi, K., Ikeda H., Kato, J., Niitsu, Y., Hamada, H. (2003). Ex vivo expansion of human umbilical cord hematopoietic progenitor cells using a coculture system with human telomerase catalytic subunit (hTERT)-transfected human stromal cells. Blood 101: 532–540.
   PubMed Web of Science ®Google Scholar
• Kempuraj, D., Saito, H., Kaneko, A., Fukagawa, K., Nakayama, M., Toru, H., Tomikawa, M., Tachimoto, H., Ebisawa, M., Akasawa, A., Miyagi T., Kimura, H., Nakajima, T., Tsuji, K., Nakahata, T. (1999). Characterization of mast cell-committed progenitors present in human umbilical cord blood. Blood 93: 3338–3346.
   PubMedGoogle Scholar
• Krauth, M.T., Böhm, A., Agis, H., Sonneck, K., Samorapoompichi, P., Florian, S., Sotlar, K., Valent, P. (2007). Effects of the CD33-targeted drug gemtuzumab ozogamicin (Mylotarg) on growth and mediator secretion in human mast cells and blood basophils. Exp Hematol 35: 108–116.
   PubMed Web of Science ®Google Scholar
• Fehlner-Gardiner, C.C., Uniyal, S., von Ballestrem, C.G., Chan, B.M. (1996). Differential utilization of VLA-4 (α4β1) and -5 (α5β1) integrins during the development of mouse bone marrow-derived mast cells. Differentiation 60: 317–325.
   PubMedGoogle Scholar
• Fehlner-Gardiner, C.C., Uniyal, S., von Ballestrem, C.G., Dougherty, G.J., Chan, B.M. (1996). Integrin VLA-6 (α6β1) mediates adhesion of mouse bone-marrow-derived mast cells to laminin. Allergy 51: 650–656.
   PubMedGoogle Scholar
• Lorentz, A., Schuppan, D., Gebert, A., Manns, M.P., Bischoff, S.C. (2002). Regulatory effects of stem cell factor and interleukin-4 on adhesion of human mast cells to extracelluar matrix proteins. Blood 99: 966–972.
   PubMed Web of Science ®Google Scholar
• Rennick, D., Hunte, B., Holland, G., Thompson-Snipes, L. (1995). Cofactors are essential for stem cell factor-dependent growth and maturation of mast cell progenitors: comparative effects of interleukin-3 (IL-3), IL-4, IL-10, and fibroblasts. Blood 85: 57–65.
   PubMedGoogle Scholar
• Yanagida, M., Fukamachi, H., Ohgami, K., Kuwaki, T., Ishii, H., Uzumaki, H., Amano, K., Tokiwa, T., Mitsui, H., Saito, H., Iikura, Y., Ishizaka, T., Nakahata, T. (1995). Effects of T-helper 2-type cytokines, interleukin-3 (IL-3), IL-4, IL-5, and IL-6 on the survival of cultured human mast cells. Blood 86: 3705–3714.
   PubMedGoogle Scholar
• Saito, H., Ebisawa, M., Tachimoto, H., Shichijo, M., Fukagawa, K., Matsumoto, K., Iikura, Y., Awaji, T., Tsujimoto, G., Yanagida, M., Uzumaki, H., Takahashi, G., Tsuji, K., Nakahata, T. (1996). Selective growth of human mast cells induced by Steel factor, IL-6, and prostaglandin E2 from cord blood mononuclear cells. J Immunol 157: 343–350.
   PubMed Web of Science ®Google Scholar
• Yuan, Q., Gurish, M.F., Friend, D.S., Austen, K.F., Boyce, J.A. (1998). Generation of a novel stem cell factor-dependent mast cell progenitor. J Immunol 161: 5143–5146.
   PubMedGoogle Scholar
• Ochi, H., Hirani, W.M., Yuan, Q., Friend, D.S., Austen, K.F., Boyce, J.A. (1999). T helper cell type 2 cytokine-mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro. J Exp Med 190: 267–280.
   PubMed Web of Science ®Google Scholar
• Welker, P., Grabbe, J., Gibbs, B., Zuberbier, T., Henz, B.M. (2000). Nerve growth factor-β induces mast-cell marker expression during in vitro culture of human umbilical cord blood cells. Immunology 99: 418–426.
   PubMedGoogle Scholar
• Bagga, S., Price, K.S., Lin, D.A., Friend, D.S., Austen, K.F., Boyce, J.A. (2004). Lysophosphatidic acid accelerates the development of human mast cells. Blood 104: 4080–4087.
   PubMedGoogle Scholar
• Price, M.M., Kapitonov, D., Allegood, J., Milstien, S., Oskeritzian, C.A., Spiegel, S. (2009). Sphingosine-1-phosphate induces development of functionally mature chymase-expressing human mast cells from hematopoietic progenitors. FASEB J 23: 3506–3515.
   PubMed Web of Science ®Google Scholar
• Sellge, G., Lorentz, A., Gebhardt, T., Levi-Schaffer, F., Bektas, H., Manns, M.P., Schuppan, D., Bischoff, S.C. (2004). Human intestinal fibroblasts prevent apoptosis in human intestinal mast cells by a mechanism independent of stem cell factor, IL-3, IL-4, and nerve growth factor. J Immunol 172: 260–267.
   PubMedGoogle Scholar
• Mierke, C., Ballmaier, M., Werner, U., Manns, M.O., Welte, K., Bischoff, S.C. (2000). Human endothelial cells regulate survival and proliferation of human mast cells. J Exp Med 192: 801–811.
   PubMedGoogle Scholar